Accumulating evidence indicates that NF-κB/p65 nuclear translocation is one of the key regulators of EMT in breast cancer and pancreatic ductal adenocarcinoma [16, 17] and that another is β-catenin in colorectal and prostate cancer [18, 19]. This evidence concerns the gene NFKB1 and Familial prostate cancer.